“The 31-GEP Stratifies Risk of Death in Patients With Stage I-IIA Cutaneous Melanoma: A SEER Real-World Evidence Study”. SKIN The Journal of Cutaneous Medicine 9, no. 4 (July 23, 2025): s586. Accessed November 16, 2025. https://skin.dermsquared.com/skin/article/view/3523.